Your Input: | |||||
| ATG12 | Ubiquitin-like protein ATG12; Ubiquitin-like protein involved in autophagic vesicle formation; Belongs to the ATG12 family. (140 aa) | ||||
| SGK1 | Non-specific serine/threonine protein kinase. (526 aa) | ||||
| GRM1 | Glutamate metabotropic receptor 1. (1195 aa) | ||||
| MAPK12 | Mitogen-activated protein kinase. (366 aa) | ||||
| EP300 | E1A binding protein p300. (2308 aa) | ||||
| MAPK13 | Mitogen-activated protein kinase. (366 aa) | ||||
| EGFR | Receptor protein-tyrosine kinase. (1141 aa) | ||||
| SETD7 | SET domain containing 7, histone lysine methyltransferase. (352 aa) | ||||
| FOXO3 | Forkhead box O3. (671 aa) | ||||
| PLK4 | Polo like kinase 4. (969 aa) | ||||
| PIK3R3 | Uncharacterized protein. (461 aa) | ||||
| PLK3 | Serine/threonine-protein kinase PLK. (768 aa) | ||||
| PRKAG2 | Protein kinase AMP-activated non-catalytic subunit gamma 2. (545 aa) | ||||
| PRKAG3 | Protein kinase AMP-activated non-catalytic subunit gamma 3. (597 aa) | ||||
| RAF1 | Raf-1 proto-oncogene, serine/threonine kinase. (668 aa) | ||||
| B9D2 | Transforming growth factor beta-1 proprotein; Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively. Transforming growth factor beta-1: Multifunctional protein that regulates the growth and differentiation of various cell types and is involved in various processes, such as normal development, immune function, microglia function and responses to neurodegeneration (By similarity). Activation into mature form fo [...] (390 aa) | ||||
| AKT2 | AKT serine/threonine kinase 2. (557 aa) | ||||
| FOXO1 | Forkhead box O1. (654 aa) | ||||
| IRS2 | Insulin receptor substrate 2. (1382 aa) | ||||
| SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1. (1353 aa) | ||||
| RAG2 | Recombination activating 2. (527 aa) | ||||
| RAG1 | V(D)J recombination-activating protein 1; Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T- lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break [...] (1071 aa) | ||||
| CAT | Catalase; Occurs in almost all aerobically respiring organisms and serves to protect cells from the toxic effects of hydrogen peroxide. Promotes growth of cells. (528 aa) | ||||
| SGK3 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (496 aa) | ||||
| PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta; Belongs to the PI3/PI4-kinase family. (1070 aa) | ||||
| PIK3R1 | Phosphoinositide-3-kinase regulatory subunit 1. (725 aa) | ||||
| CCNG2 | Cyclin G2; Belongs to the cyclin family. (343 aa) | ||||
| PRKAG1 | Protein kinase AMP-activated non-catalytic subunit gamma 1. (330 aa) | ||||
| HOMER1 | Homer scaffold protein 1. (354 aa) | ||||
| MAPK10 | Mitogen-activated protein kinase. (467 aa) | ||||
| NRAS | Uncharacterized protein. (189 aa) | ||||
| CHUK | Component of inhibitor of nuclear factor kappa B kinase complex. (745 aa) | ||||
| TGFB2 | Transforming growth factor beta; Belongs to the TGF-beta family. (442 aa) | ||||
| IL10 | Interleukin-10; Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines in [...] (179 aa) | ||||
| EGF | Pro-epidermal growth factor; EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6 (By similarity). (1211 aa) | ||||
| G6PC2 | Glucose-6-phosphatase; Belongs to the glucose-6-phosphatase family. (356 aa) | ||||
| PCK2 | Phosphoenolpyruvate carboxykinase 2, mitochondrial. (794 aa) | ||||
| CDKN1B | Cyclin-dependent kinase inhibitor 1B; Important regulator of cell cycle progression. Inhibits the kinase activity of CDK2 bound to cyclin A, but has little inhibitory activity on CDK2 bound to SPDYA. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry. (198 aa) | ||||
| SIRT1 | Sirtuin 1. (745 aa) | ||||
| BCL6 | B-cell lymphoma 6 protein. (706 aa) | ||||
| SOS2 | SOS Ras/Rho guanine nucleotide exchange factor 2. (1375 aa) | ||||
| HOMER3 | Homer scaffold protein 3. (360 aa) | ||||
| G6PC | Glucose-6-phosphatase; Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. Forms with the glucose-6-phosphate transporter (SLC37A4/G6PT) the complex responsible for glucose production through glycogenolysis and gluconeogenesis. Hence, it is the key enzyme in homeostatic regulation of blood glucose levels (By similarity). (357 aa) | ||||
| FASLG | Tumor necrosis factor ligand 1A; Belongs to the tumor necrosis factor family. (286 aa) | ||||
| PIK3R2 | Uncharacterized protein. (726 aa) | ||||
| ARAF | A-Raf proto-oncogene, serine/threonine kinase. (605 aa) | ||||
| CCND2 | Cyclin D2; Belongs to the cyclin family. (328 aa) | ||||
| AKT3 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (479 aa) | ||||
| CCNB2 | Cyclin N-terminal domain-containing protein; Belongs to the cyclin family. (397 aa) | ||||
| TGFB3 | Transforming growth factor beta 3. (457 aa) | ||||
| SMAD3 | Mothers against decapentaplegic homolog. (611 aa) | ||||
| IRS4 | Insulin receptor substrate 4. (1275 aa) | ||||
| AKT1 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (480 aa) | ||||
| NLK | Serine/threonine-protein kinase NLK; Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhi [...] (527 aa) | ||||
| SKP2 | S-phase kinase associated protein 2. (436 aa) | ||||
| IL7R | Interleukin 7 receptor. (456 aa) | ||||
| PRKAA2 | Non-specific serine/threonine protein kinase. (532 aa) | ||||
| USP7 | Ubiquitin specific peptidase 7; Belongs to the peptidase C19 family. (1086 aa) | ||||
| S1PR4 | Sphingosine-1-phosphate receptor 4. (383 aa) | ||||
| GADD45B | Growth arrest and DNA damage inducible beta. (160 aa) | ||||
| STK11 | Serine/threonine kinase 11; Belongs to the protein kinase superfamily. (439 aa) | ||||
| PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta; Belongs to the PI3/PI4-kinase family. (1083 aa) | ||||
| S1PR1 | Sphingosine-1-phosphate receptor 1; Belongs to the G-protein coupled receptor 1 family. (389 aa) | ||||
| CCNB1 | Uncharacterized protein; Belongs to the cyclin family. (425 aa) | ||||
| MAPK1 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (360 aa) | ||||
| BNIP3 | BCL2 interacting protein 3. (354 aa) | ||||
| FBXO32 | F-box protein 32. (355 aa) | ||||
| ATM | Serine-protein kinase ATM; Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]- Q. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and mo [...] (3056 aa) | ||||
| CREBBP | CREB binding protein. (2442 aa) | ||||
| INSR | Tyrosine-protein kinase receptor. (1406 aa) | ||||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2. (760 aa) | ||||
| PLK1 | Serine/threonine-protein kinase PLK. (604 aa) | ||||
| PRKAB2 | Protein kinase AMP-activated non-catalytic subunit beta 2. (272 aa) | ||||
| GABARAPL2 | GABA type A receptor associated protein like 2. (117 aa) | ||||
| HRAS | Uncharacterized protein. (189 aa) | ||||
| TGFBR1 | Receptor protein serine/threonine kinase; Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. (509 aa) | ||||
| STK4 | Serine/threonine kinase 4. (514 aa) | ||||
| MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2; Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (By similarity). (442 aa) | ||||
| SOD2 | Superoxide dismutase [Mn], mitochondrial. (570 aa) | ||||
| IGF1R | Tyrosine-protein kinase receptor. (1403 aa) | ||||
| PTEN | Phosphatase and tensin homolog; Tumor suppressor. Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine- phosphorylated proteins. Also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4- diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5- tetrakisphosphate with order of substrate preference in vitro PtdIns(3,4,5)P3 > PtdIns(3,4)P2 > PtdIns3P > Ins(1,3,4,5)P4. The lipid phosphatase activity is critical for its tumor [...] (403 aa) | ||||
| MAP2K1 | Mitogen-activated protein kinase kinase 1; Belongs to the protein kinase superfamily. (478 aa) | ||||
| GADD45A | Growth arrest and DNA damage inducible alpha. (246 aa) | ||||
| MAPK8 | Mitogen-activated protein kinase. (427 aa) | ||||
| IKBKB | Inhibitor of nuclear factor kappa B kinase subunit beta. (756 aa) | ||||
| MAPK14 | Mitogen-activated protein kinase 14; Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are a [...] (360 aa) | ||||
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. (1068 aa) | ||||
| CDKN2D | Cyclin dependent kinase inhibitor 2D. (166 aa) | ||||
| PLK2 | Polo like kinase 2. (692 aa) | ||||
| GRB2 | Growth factor receptor bound protein 2. (250 aa) | ||||
| PRMT1 | Protein arginine methyltransferase 1; Belongs to the class I-like SAM-binding methyltransferase superfamily. Protein arginine N-methyltransferase family. (648 aa) | ||||
| FOXO4 | Forkhead box O4. (558 aa) | ||||
| PRKAB1 | Protein kinase AMP-activated non-catalytic subunit beta 1. (275 aa) | ||||
| CDKN1A | Cyclin dependent kinase inhibitor 1A. (357 aa) | ||||
| STAT3 | Signal transducer and activator of transcription. (793 aa) | ||||
| PRKAA1 | Non-specific serine/threonine protein kinase. (573 aa) | ||||
| INS | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. (232 aa) | ||||
| GABARAPL1 | GABA type A receptor associated protein like 1. (142 aa) | ||||
| SMAD4 | Mothers against decapentaplegic homolog. (552 aa) | ||||
| IL6 | Interleukin-6; Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Required for the generation of T(H)17 cells. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. It induces myeloma and plasm [...] (246 aa) | ||||
| PDPK1 | 3-phosphoinositide dependent protein kinase 1. (551 aa) | ||||
| FBXO25 | F-box protein 25. (373 aa) | ||||
| CSNK1E | Casein kinase 1 epsilon; Belongs to the protein kinase superfamily. (431 aa) | ||||
| RBL2 | RB transcriptional corepressor like 2. (1162 aa) | ||||
| IGF1 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] (195 aa) | ||||
| SGK2 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (367 aa) | ||||
| CCND1 | G1/S-specific cyclin-D1; Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. A [...] (331 aa) | ||||
| MAPK11 | Mitogen-activated protein kinase. (231 aa) | ||||
| TNFSF10 | Tumor necrosis factor ligand superfamily member. (296 aa) | ||||
| CCNB3 | G2/mitotic-specific cyclin-B3; Cyclins are positive regulatory subunits of the cyclin- dependent kinases (CDKs), and thereby play an essential role in the control of the cell cycle, notably via their destruction during cell division. Its tissue specificity suggest that it may be required during early meiotic prophase I (By similarity). (1352 aa) | ||||
| TGFBR2 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (561 aa) | ||||
| MAPK9 | Mitogen-activated protein kinase. (424 aa) | ||||
| SLC2A4 | Solute carrier family 2, facilitated glucose transporter member 4; Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. (553 aa) | ||||
| MDM2 | E3 ubiquitin-protein ligase Mdm2; E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 [...] (529 aa) | ||||